Shattuck Labs, Inc. · NASDAQ:STTK
Orbimed Advisors LLC reported a 9.99% stake in Shattuck Labs, Inc. (Schedule 13D)
Event Aug 25, 2025 · Filed Sep 2, 2025
Orbimed Advisors LLC reported a 9.99% stake in Shattuck Labs, Inc., 6,306,127 shares, with active intent on Aug 25, 2025. Filed Sep 2, 2025 (Schedule 13D).
- Stake
- 9.99%
- Shares
- 6,306,127
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 9.99% | 6,306,127 |
| OrbiMed Capital GP IX LLC | 8.32% | 5,255,106 |
| OrbiMed Genesis GP LLC | 1.67% | 1,051,021 |
Source
Related
- Shattuck Labs, Inc.
- Orbimed Advisors LLC
- Shattuck Labs, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Jun 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 17, 2026
- Form 4 · Shukla Abhinav A. · Jul 7, 2026
- Form 4 · Shukla Abhinav A. · Jul 2, 2026
- Form 4 · Pandite Arundathy N. · Jul 2, 2026